These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 27871075

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparative effectiveness of angiotensin receptor blockers vs. angiotensin-converting enzyme inhibitors on cardiovascular outcomes in patients initiating peritoneal dialysis.
    Shen JI, Saxena AB, Montez-Rath ME, Leng L, Chang TI, Winkelmayer WC.
    J Nephrol; 2017 Apr; 30(2):281-288. PubMed ID: 27485007
    [Abstract] [Full Text] [Related]

  • 3. Renin-angiotensin system blockers and residual kidney function loss in patients initiating peritoneal dialysis: an observational cohort study.
    Shen JI, Saxena AB, Vangala S, Dhaliwal SK, Winkelmayer WC.
    BMC Nephrol; 2017 Jun 17; 18(1):196. PubMed ID: 28623899
    [Abstract] [Full Text] [Related]

  • 4. Effects of angiotensin converting enzyme inhibition or angiotensin receptor blockade in dialysis patients: a nationwide data survey and propensity analysis.
    Wu CK, Yang YH, Juang JJ, Wang YC, Tsai CT, Lai LP, Hwang JJ, Chiang FT, Chen PC, Lin JL, Lin LY.
    Medicine (Baltimore); 2015 Jan 17; 94(3):e424. PubMed ID: 25621694
    [Abstract] [Full Text] [Related]

  • 5. End-stage renal disease patients using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may reduce the risk of mortality: a Taiwanese Nationwide cohort study.
    Lee HF, See LC, Chan YH, Yeh YH, Wu LS, Liu JR, Tu HT, Wang CL, Kuo CT, Chang SH.
    Intern Med J; 2018 Sep 17; 48(9):1123-1132. PubMed ID: 29808610
    [Abstract] [Full Text] [Related]

  • 6. Renoprotective effect of renin-angiotensin-aldosterone system blockade in patients with predialysis advanced chronic kidney disease, hypertension, and anemia.
    Hsu TW, Liu JS, Hung SC, Kuo KL, Chang YK, Chen YC, Hsu CC, Tarng DC.
    JAMA Intern Med; 2014 Mar 17; 174(3):347-54. PubMed ID: 24343093
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A comparison between angiotensin converting enzyme inhibitors and angiotensin receptor blockers on end stage renal disease and major adverse cardiovascular events in diabetic patients: a population-based dynamic cohort study in Taiwan.
    Wu LS, Chang SH, Chang GJ, Liu JR, Chan YH, Lee HF, Wen MS, Chen WJ, Yeh YH, Kuo CT, See LC.
    Cardiovasc Diabetol; 2016 Apr 02; 15():56. PubMed ID: 27039185
    [Abstract] [Full Text] [Related]

  • 9. Is Chronic Kidney Disease Progression Influenced by the Type of Renin-Angiotensin-System Blocker Used?
    Silvariño R, Rios P, Baldovinos G, Chichet MA, Perg N, Sola L, Saona G, De Souza N, Lamadrid V, Gadola L.
    Nephron; 2019 Apr 02; 143(2):100-107. PubMed ID: 31203280
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Combined angiotensin-converting enzyme inhibition and receptor blockade associate with increased risk of cardiovascular death in hemodialysis patients.
    Chan KE, Ikizler TA, Gamboa JL, Yu C, Hakim RM, Brown NJ.
    Kidney Int; 2011 Nov 02; 80(9):978-985. PubMed ID: 21775975
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Myocardial Infarction Patients With Renal Dysfunction.
    Evans M, Carrero JJ, Szummer K, Åkerblom A, Edfors R, Spaak J, Jacobson SH, Andell P, Lindhagen L, Jernberg T.
    J Am Coll Cardiol; 2016 Apr 12; 67(14):1687-97. PubMed ID: 27056774
    [Abstract] [Full Text] [Related]

  • 13. No impact of hyperkalaemia with renin-angiotensin system blockades in maintenance haemodialysis patients.
    Han SW, Won YW, Yi JH, Kim HJ.
    Nephrol Dial Transplant; 2007 Apr 12; 22(4):1150-5. PubMed ID: 17255126
    [Abstract] [Full Text] [Related]

  • 14. Angiotensin receptor blockers are associated with lower mortality than ACE inhibitors in predialytic stage 5 chronic kidney disease: A nationwide study of therapy with renin-angiotensin system blockade.
    Lin CC, Wu YT, Yang WC, Tsai MJ, Liu JS, Yang CY, Li SY, Ou SM, Tarng DC, Hsu CC.
    PLoS One; 2017 Apr 12; 12(12):e0189126. PubMed ID: 29216260
    [Abstract] [Full Text] [Related]

  • 15. Cardiovascular death in kidney recipients treated with renin-angiotensin system blockers.
    Opelz G, Döhler B.
    Transplantation; 2014 Feb 15; 97(3):310-5. PubMed ID: 24492421
    [Abstract] [Full Text] [Related]

  • 16. Renin-angiotensin system blockade in heart failure patients on long-term haemodialysis in Taiwan.
    Tang CH, Chen TH, Wang CC, Hong CY, Huang KC, Sue YM.
    Eur J Heart Fail; 2013 Oct 15; 15(10):1194-202. PubMed ID: 23671265
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Interactive Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers or Their Combination on Survival of Hemodialysis Patients.
    Kido R, Akizawa T, Fukagawa M, Onishi Y, Yamaguchi T, Fukuhara S.
    Am J Nephrol; 2017 Oct 15; 46(6):439-447. PubMed ID: 29161689
    [Abstract] [Full Text] [Related]

  • 20. Renin-Angiotensin System Inhibition and Lower 30-Day All-Cause Readmission in Medicare Beneficiaries with Heart Failure.
    Sanam K, Bhatia V, Bajaj NS, Gaba S, Morgan CJ, Fonarow GC, Butler J, Deedwania P, Prabhu SD, Wu WC, White M, Love TE, Aronow WS, Fletcher RD, Allman RM, Ahmed A.
    Am J Med; 2016 Oct 15; 129(10):1067-73. PubMed ID: 27262781
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.